2026年01月22日 FRONTEO and TAGCyx Bio concluded a PoC feasibility agreement to explore new therapeutic targets and indications for artificial nucleic acid aptamers utilizing Drug Discovery AI Factory
2025年11月13日 FRONTEO and UBE Sign Memorandum of Understanding for Joint Research Utilizing Drug Discovery AI Factory Aimed at Out-Licensing Innovative Drug Discovery Seeds
2025年08月26日 FRONTEO Presents Research on Exploring the Mechanism of Action of a Kampo Medicine Using the “Drug Discovery AI Factory”
2025年08月18日 FRONTEO Signs Phase 2 Agreement with Daiichi Sankyo on Toxicity Information Analysis Using the Drug Discovery AI Factory
